Skip to content

Interactive Group Drumming (IGD) in Hospital Experience of Patients Undergoing Hematopoietic Stem Cell Transplant - A Pilot Study

Does Interactive Group Drumming (IGD) Improve the Hospital Experience of Patients Undergoing Hematopoietic Stem Cell Transplant? - A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03345433
Enrollment
35
Registered
2017-11-17
Start date
2017-11-15
Completion date
2019-12-04
Last updated
2020-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic Cell Transplant

Brief summary

The purpose of this research is to determine if it is possible to perform group drumming as an intervention during HCT, to begin to understand how interactive group drumming during HCT treatment affects patients' well-being (good and bad) during the treatment course and in the first four weeks after completion of the drumming sessions.

Detailed description

The purpose of this research is to determine if it is possible to perform group drumming as an intervention during HCT, to begin to understand how interactive group drumming during HCT treatment affects patients' well-being (good and bad) during the treatment course and in the first four weeks after completion of the drumming sessions.

Interventions

BEHAVIORALinteractive group drumming sessions

interactive group drumming sessions

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

interactive group drumming sessions

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* People who are at least 18 years old and are scheduled for HCT * Individuals must be able to understand and willing to sign a written informed consent form

Exclusion criteria

* People who are too ill to participate, i.e., while they are in contact isolation or have low platelets (less than 20,000/mcl) will not participate until their condition has improved. * Patients receiving outpatient HCT except patients with multiple myeloma. Patients with multiple myeloma may participate in the study even though they tend to spend nights away from the hospital.

Design outcomes

Primary

MeasureTime frameDescription
Rate of participationUp to 1 week after hematopoietic cell transplant (HCT)Defined as the number of subjects willing to participate in the interactive group drumming (IGD) divided by the number approached and asked to participate. These rates will be reported, along with the corresponding 95% confidence interval.
Rate of completionUp to 1 week after HCTDefined as the ratio of (the number of individuals who successfully complete the study \[4 sessions of IGD (about 20 minutes \[min.\] each)\], with two pre-and post- surveys \[8 minutes total, and two questionnaires (10 minutes total) about 160 minutes total time\]) relative to the number of individuals who consent to the study (the number from the numerator of the first ratio \[participation\]). These rates will be reported, along with the corresponding 95% confidence interval.

Secondary

MeasureTime frameDescription
Gather patient-reported information to study whether the effect of interactive group drumming (IGD) on targeted variables is more pronounced in successive sessionsBaseline up to 4 weeks after completion of IGDTargeted variables defined as anxiety, energy mood, distress, relaxation, pain, and patient satisfaction. Will compare for each participant. The mean and standard deviation for each of these measures will be calculated.
Effect of support care provider (SCP) presence for each participant and among participantsUp to 4 weeks after completion of IGDWill use a non-parametric test to compare difference in item scores with and without SCP presence.
Gather patient-reported data to suggest how participants respond to interactive group drumming (IGD)Baseline up to 4 weeks after completion of IGDWill be assessed by STADID Short Form Y-1. The after-IGD session measure will include a patient satisfaction item as well. The mean and standard deviation for each of these measures will be calculated.
Gather patient-reported information to suggest the optimal number of interactive group drumming (IGD) sessionsBaseline up to 4 weeks after completion of IGDWill be assessed by STADID Short Form Y-1. The after-IGD session measure will include a patient satisfaction item as well. The mean and standard deviation for each of these measures will be calculated
Change in physiological response to interactive group drumming (IGD)Baseline up to 1 week after HCTWill be calculated at three time points during the session; repeated measures analysis of variance will be used to detect changes over the 3 readings.
Determine optimum length of sessionUp to 4 weeks after completion of IGDWill be assessed by comparing actual length of session reported on facilitator post-session observation forms with participant satisfaction as reported in post-session. The mean and standard deviation for each of these measures will be calculated.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026